Insider · CIK 0001752139
Becker Daniel J.
Reports to the SEC for 5 companies · HENDERSON, NV
Transactions
49
Companies
5
Filings
13
CIK
0001752139
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-17 | ZURAZura Bio Ltd · Share Option (Right to Buy)A Award | — |
| 2025-05-29 | ZURAZura Bio Ltd · Share Option (Right to Buy)A Award | — |
| 2025-05-21 | ACELYRIN, Inc.D Disposition to Issuer | — |
| 2025-05-21 | ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-05-21 | ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-07-17 | ACELYRIN, Inc.S Sale | −$6.86 |
| 2024-06-07 | ACELYRIN, Inc.Director Stock Option (right to buy)A Award | — |
| 2023-06-22 | DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award | — |
| 2023-05-09 | ACELYRIN, Inc.Director Stock Option (right to buy)J Other | — |
| 2023-05-09 | ACELYRIN, Inc.Director Stock Option (right to buy)J Other | — |
| 2023-05-09 | ACELYRIN, Inc.P Purchase | +$54K |
| 2023-05-04 | ACELYRIN, Inc.Director Stock Option (right to buy)A Award | — |
| 2022-06-21 | DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award | — |
| 2021-06-01 | DAWNDay One Biopharmaceuticals, Inc.P Purchase | +$80K |
| 2021-05-26 | DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award | — |
| 2021-04-01 | Pandion Therapeutics, Inc.U Disposition from Tender | −$170M |
| 2021-04-01 | Pandion Therapeutics, Inc.U Disposition from Tender | −$60K |
| 2021-04-01 | Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-11-19 | Pandion Therapeutics, Inc.P Purchase | +$2.99M |
| 2020-11-18 | Pandion Therapeutics, Inc.P Purchase | +$217K |
| 2020-11-17 | Pandion Therapeutics, Inc.P Purchase | +$201K |
| 2020-11-17 | Pandion Therapeutics, Inc.P Purchase | +$31.7K |
| 2020-09-28 | Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer | — |
| 2020-09-28 | Principia Biopharma Inc.U Disposition from Tender | −$66.8M |
| 2020-09-28 | Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer | — |
| 2020-09-28 | Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer | — |
| 2020-07-21 | Pandion Therapeutics, Inc.P Purchase | +$13M |
| 2020-07-21 | Pandion Therapeutics, Inc.P Purchase | +$18K |
| 2020-07-21 | Pandion Therapeutics, Inc.Series B Preferred StockC Conversion | — |
| 2020-07-21 | Pandion Therapeutics, Inc.C Conversion | — |
| 2020-07-17 | Pandion Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2020-06-04 | Principia Biopharma Inc.Director Stock Option (right to buy)A Award | — |
| 2019-11-20 | Principia Biopharma Inc.P Purchase | +$1.65M |
| 2019-10-29 | Principia Biopharma Inc.P Purchase | +$312K |
| 2019-10-28 | Principia Biopharma Inc.P Purchase | +$2.29M |
| 2019-10-18 | Principia Biopharma Inc.P Purchase | +$15M |
| 2019-06-11 | Principia Biopharma Inc.Director Stock Option (right to buy)A Award | — |
| 2018-09-18 | Principia Biopharma Inc.Series B-3 Convertible Preferred StockC Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.Series C Convertible Preferred StockC Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.P Purchase | +$4.59M |
| 2018-09-18 | Principia Biopharma Inc.C Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.C Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.C Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.C Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.C Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.Series B-1 Convertible Preferred StockC Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.Series B-2 Convertible Preferred StockC Conversion | — |
| 2018-09-18 | Principia Biopharma Inc.Series A Convertible Preferred StockC Conversion | — |
| 2018-09-13 | Principia Biopharma Inc.Director Stock Option (right to buy)A Award | — |
Recent filings
- 4Becker Daniel J.0001752139-26-000002SEC(opens sec.gov)
- 4Becker Daniel J.0001415889-25-014939SEC(opens sec.gov)
- 4Becker Daniel J.0001962918-25-000052SEC(opens sec.gov)
- 4Becker Daniel J.0001962918-24-000099SEC(opens sec.gov)
- 4Becker Daniel J.0001962918-24-000093SEC(opens sec.gov)
- 4Becker Daniel J.0001209191-23-039802SEC(opens sec.gov)
- 4Becker Daniel J.0001209191-23-028874SEC(opens sec.gov)
- 4Becker Daniel J.0001209191-23-027524SEC(opens sec.gov)
- 4Becker Daniel J.0001209191-22-039047SEC(opens sec.gov)
- 4Becker Daniel J.0001209191-21-037023SEC(opens sec.gov)
- 4Becker Daniel J.0000899243-21-014451SEC(opens sec.gov)
- 4Becker Daniel J.0000899243-20-031941SEC(opens sec.gov)
- 4Becker Daniel J.0000899243-20-031744SEC(opens sec.gov)
Companies
Address
C/O ZURA BIO LTD 1489 W. WARM SPRINGS RD. #110
HENDERSON, NV, 89014